Proteins of the Ras pathway as novel potential anticancer therapeutic targets

Cell Biology and Toxicology

Volumn 15, Issue 6, 1999, Pages 345-358

  De Gunzburg, Jean ^a  

^a INSERM   (France)

Author keywords

Anticancer drugs; GTPase; Oncogenesis; Ras; Signal transduction

Indexed keywords

ANTINEOPLASTIC AGENT; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN;

ANTINEOPLASTIC ACTIVITY; CONFERENCE PAPER; EFFECTOR CELL; ENZYME ACTIVATION; MOLECULAR CLONING; ONCOGENE RAS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; VIRUS TRANSFORMATION;

ANIMALS; ANTINEOPLASTIC AGENTS; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RAS PROTEINS; SIGNAL TRANSDUCTION;

EID: 0033510360     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007645631013     Document Type: Conference Paper

References (155)

1. Adari H, Lowy, DR, Willumsen BM, Der CJ, McCormick F. Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain. Science. 1988; 240:518-21.
2. Ahmadian MR, Zor T, Vogt D, et al. Guanosine triphosphatase stimulation of oncogenic Ras mutants. Proc Natl Acad Sci USA. 1999;96:7065-70.
3. Aktas H, Cai H, Cooper GM. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27(KIP1). Mol Cell Biol. 1997;17:3850-7.
4. Albright CF, Giddings BW, Liu J, Vito M, Weinberg RA. Characterization of a guanine nucleotide dissociation stimulator for a ras-related GTPase. EMBO J. 1993;12:339-47.
5. Barbacid M. Ras genes. Annu Rev Biochem. 1987;56:779-828.
6. Barnard D, Sun HY, Baker L, Marshall MS. In vitro inhibition of Ras-Raf association by short peptides. Biochem Biophys Res Commun. 1998;247:176-80.
7. Barrington RE, Subler MA, Rands E, et al. A farnesyltransferase inhibitor induces tumor regression in transgenic mice harboring multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosis. Mol Cell Biol. 1998;18:85-92.
8. ARF links the tumour suppressors RB and p53. Nature. 1998;395:124-5.
9. Béranger F, Paterson H, Powers S, de Gunzburg J, Hancock J. The effector domain of Rab6 plus a highly hydrophobic C-terminus is required for Golgi targeting. Mol Cell Biol. 1994;14:744-58.
10. Boguski MS, McCormick F. Proteins regulating Ras and its relatives. Nature. 1993;366: 643-54.
11. Boriack-Sjodin PA, Margarit SM, BarSagi D, Kuriyan J. The structural basis of the activation of Ras by Sos. Nature. 1998;394:337-43.
12. Bos H. Ras oncogenes in human cancer. Cancer Res. 1989;49: 4682-9.
13. Bourne HR. How receptors talk to trimeric G proteins. Curr Opin Cell Biol. 1997;9:134-42.
14. Bourne HR, Sanders DA, McCormick F. The GTPase superfamily: a conserved switch for diverse cell functions. Nature. 1990;348:125-32.
15. Bourne HR, Sanders DA, McCormick F. The GTPase superfamily: conserved structure and molecular mechanism. Nature. 1991;349:117-27.
16. Boyartchuk VL, Ashby MN, Rine J. Modulation of Ras and a-factor function by carboxyl-terminal proteolysis. Science. 1997;275:1796-800.
17. Burgering BMT, Coffer P J. Protein kinase B (c-Akt) in phosphatodylinositol-3-OH kinase signal transduction. Nature. 1995;376:599-602.
18. Campbell SL, KhosraviFar R, Rossman KL, Clark GJ, Der CJ. Increasing complexity of Ras signaling. Oncogene. 1998;17: 1395-413.
19. Cantor S, Urano T, Feig LA. Identification and characterisation of Ral-binding protein 1, a potential downstream target of Ra1 GTPases. Mol Cell Biol. 1995;15:4578-84.
20. Carpenter CC, Cantley LC. Phosphoinositide kinases. Curr Opin Cell Biol. 1996;8:153-8.
21. Casey PJ, Seabra MC. Protein prenyltransferases. J Biol Chem. 1996;271:5289-92.
22. Chardin P. Small GTP-binding proteins of the Ras family. A conserved functional mechanism. Cancer Cells. 1991;3:117-26.
23. Chardin P, Camonis JH, Gane N, van Aelst L, Wigler SJM, Bar Sagi D. Human Sos1: a guanine nucleotide exchange factor for Ras that binds Grb2. Science. 1993;260:1338-43.
24. Chavrier P, Gorvel J-P, Stelzer E, Simons K, Gruenberg J, Zerial M. Hypervariable C-terminal domain of rab proteins acts as a targeting signal. Nature. 1991;353:769-72.
25. Chen D, Waters SB, Holt KH, Pessin JE. Sos phosphorylation and diassociation of the Grb2-Sos complex by ERK and JNK signaling pathways. J Biol Chem. 1996;271:6328-32.
26. Choy E, Chiu VK, Silletti J, et al. Endomembrane trafficking of Ras: the CAAX motif targets proteins to the ER and Golgi. Cell. 1999;98:69-80.
27. Chuang E, Barnard D, Hettich L, Zhang XF, Avruch J, Marshall M. Critical binding and regulatory interactions between Ras and Raf occur through a small, stable N-terminal domain of Raf and specific Ras effector residues. Mol Cell Biol. 1994;14:5318-25.
28. Clark GJ, Drugan JK, Terrell RS, et al. Peptides containing a consensus Ras binding sequence from Raf-1 and the GTPase activating protein NF1 inhibit Ras function. Proc Natl Acad Sci USA. 1996;93:1577-81.
29. Clarke S. Protein isoprenylation at carboxyl terminal cysteine residues. Annu Rev Biochem. 1992;61:355-86.
30. Clarke S, Vogel JP, Deschenes RJ, Stock J. Post-translational modification of the H-ras oncogene protein: evidence for a third class of protein carboxyl methyltransferase. Proc Natl Acad Sci USA. 1988;85:4643-7.
31. Cobb MH. MAP kinase pathways. Prog Biophys Mol Biol. 1999;71:479-500.
32. Cowsert LM. In vitro and in vivo activity of antisense inhibitors of ras: potential for clinical development. Anticancer Drug Des. 1997;12:359-71.
33. 4-binding protein as a member of the GAP1 family. Nature. 1995;376:527-30.
34. Dai Q, Choy E, Chiu V, et al. Mammalian prenylcysteine carboxymethyl tranferase is in the endoplasmic reticulum. J Biol Chem. 1998;273:15030-4.
35. Daub M, Jockel J, Quack T, et al. The RafC1 cysteine-rich domain contains multiple distinct regulatory epitopes which control Ras-dependent Raf activation. Mol Cell Biol. 1998; 18:6698-710.
36. Daum G, Eisenmanntappe I, Fries HW, Troppmair J, Rapp U. The ins and outs of Raf kinases. Trends Biochem Sci. 1994;19:474-80.
37. Denouel Galy A, Douville EM, Warne PH, et al. Murine Ksr interacts with MEK and inhibits Ras-induced transformation. Curr Biol. 1998;8:46-55.
38. Diaz-Meco MT, Lozano J, Municio MM, et al. Evidence for the in vitro and in vivo interaction of Ras with protein kinase C zeta. J Biol Chem. 1994;271:588-94.
39. Downward J. Ras signalling and apoptosis. Curr Opin Genet Dev. 1998;8:49-54.
40. ras. Proc Natl Acad Sci USA. 1990;87:5998-6002.
41. Du W, Lebowitz PF, Prendergast GC. Cell growth inhibition by farnesyltransferase inhibitors is mediated by gain of geranylgeranylated RhoB. Mol Cell Biol. 1999;19:1831-40).
42. Egan S, Weinberg RA. The pathway to signal achievement. Nature. 1993;365:781-3.
43. Egozi Y, Weisz B, GanaWeisz M, BenBaruch G, Kloog Y. Growth inhibition of ras-dependent tumors in nude mice by a potent ras-dislodging antagonist. Int J Cancer. 1999; 80:911-18.
44. Franke TF, Yang SI, Chan TO, et al. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell. 1995;81:727-36.
45. Franke TF, Kaplan DR, Cantley L. PI3K: downstream AK-Tion blocks apoptosis. Cell. 1997;88:435-7.
46. Frech M, Andjelkovic M, Ingley E, Reddy KK, Falck JR, Hemmings BA. High affinity binding of inositol phosphates and phosphoinositides to the Pleckstrin homology domain of RAC protein kinase B and their influence on kinase activity. J Biol Chem. 1997;272:8474-81.
47. Gibbs JB, Olif, A. The potential of farnesyltransferase inhibitors as cancer chemotherapeutics. Annu Rev Pharmacol Toxicol. 1999;37:143-66.
48. Gibbs JB, Pompliano DL, Mosser SD, et al. Selective inhibition of farnesyl-protein transferase blocks Ras processing in vivo. J Biol Chem. 1993;268:7617-20.
49. Gideon P, John J, Frech M, et al. Mutational and kinetic analyses of the GTPase activating protein (GAP)-p21 interaction: the C-terminal domain of GAP is not sufficient for full activity. Mol Cell Biol. 1992;12:2050-6.
50. Gille H, Sharrocks AD, Shaw PE. Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature. 1992;358:414-17.
51. Haklai R, Weisz MG, Elad G, et al. Dislodgment and accelerated degradation of Ras. Biochemistry. 1998;37: 1306-14.
52. Hall A. Rho GTPases and the actin cytoskeleton. Science. 1998;279:509-14.
53. Hamm HE. The many faces of G protein signaling. J Biol Chem. 1998;273:669-72.
54. Han L, Colicelli J. A human protein selected for interference with Ras function interacts directly with Ras and competes with Rafl. Mol Cell Biol. 1995;15:1318-23.
55. Han L, Wong D, Dhaka A, et al. Protein binding and signaling properties of RIN1 suggest a unique effector function. Proc Natl Acad Sci USA. 1997;94:4954-9.
56. Hancock JF, Magee AI, Childs JE, Marshall CJ. All ras proteins are polyisoprenylated but only some are palmitoylated. Cell. 1989;57:1167-77.
57. ras to the plasma membrane. Cell. 1990;63:133-9.
58. Hancock J, Cadwallader K, Paterson H, Marshall C. A CAAX or a CAAL motif and a second signal are sufficient for plasma membrane targeting of ras proteins. EMBO J. 1991a;10:4033-9.
59. K-ras(B). EMBO J. 1991b;10:641-6.
60. Hart MJ, de los Santos R, Albert IN, Rubinfeld B, Polakis P. Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta. Curr Biol 1998;8:573-81.
61. Herrmann C, Martin GA, Wittinghofer A. Quantitative analysis of the complex between p21ras and the Ras-binding domain of the human Raf-1 protein kinase. J Biol Chem. 1995;270:2901-5.
62. Hofer F, Fields S, Schneider C, Martin GS. Activated Ras interacts with the Ra1 guanine nucleotide dissociation stimulator. Proc Natl Acad Sci USA. 1994;91:11089-93.
63. Howe LR, Leevers SJ, Gomez N, Nakielny S, Cohen P, Marshal CJ. Activation of the MAP kinase pathway by the protein kinase raf. Cell. 1992;71:335-42.
64. Hu CD, Kariya K, Okada T, Qi XD, Song CH, Kataoka T. Effect of phosphorylation on activities of Rap1A to interact with Raf-1 and to suppress Ras-dependent Raf-1 activation. J Biol Chem. 1999;274:48-51.
65. Huang L, Hofer F, Martin GS, Kim SH. Structural basis for the interaction of Ras with RaIGDS. Nature Struct Biol. 1998;5:422-6.
66. John J, Sohmen R, Feuerstein J, Linke R, Wittinghofer A, Goody RS. Kinetics of interaction of nucleotides with nucleotide-free H-ras p21. J Biol Chem. 1990;265.
67. Joneson T, White MA, Wigler MH, Bar-Sagi D. Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of Ras. Science. 1996;271:810-12.
68. Jullien-Flores V, Dorseuil O, Romero F, et al. Bridging Ra1 GTPase to Rho pathways. J Biol Chem. 1995;270:22473-7.
69. Kauffman-Zeh A, RodriguezViciana P, Ulrich E, et al. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature. 1997;385:544-8.
70. Khosravi-Far R, White MA, Westwick JK, et al. Oncogenic Ras activation of Ras/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation. Mol Cell Biol. 1996;16:3923-33.
71. Kikuchi A, Demo SD, Ye ZH, Chen YW, Williams L. ra1GDS family members interact with the effector loop of ras p21. Mol Cell Biol. 1994;14:7483-91.
72. Kim E, Ambroziak P, Otto JC, et al. Disruption of the mouse Rce1 gene results in defective Ras processing and mislocalization of Ras within cells. J Biol Chem. 1999;274:8383-90.
73. Kops G, deRuiter ND, DeVriesSmits AMM, Powell DR, Bos JL, Burgering BMT. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature. 1999;398:630-4.
74. Kuriyama M, Harada N, Kuroda S, et al. Identification of AF-6 and Canoe as putative targets for Ras. J Biol Chem. 1996; 271:607-10.
75. Lebowitz PF, Prendergast, GC. Non-Ras targets of farnesyltransferase inhibitors: focus on Rho. Oncogene. 1998;17: 1439-45.
76. Leevers SJ, Marshall CJ. Activation of extracellular signal-regulated kinase, ERK2, by p21 ras oncoprotein. EMBO J. 1992;11:569-74.
77. Leevers SJ, Paterson H, Marshall CJ. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature. 1994;369:411-14.
78. Lenormand P, Sardet C, Pages G, L'Allemain G, Brunet A, Poyssegur J. Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts. J Cell Biol. 1993; 122:1079-88.
79. Leone G, DeGregori J, Sears R, Jakol L, Nevins JR. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature. 1997;387:422-26.
80. Lockyer PJ, Wennstrom S, Kupzig S, Venkateswarlu K, Downward J, Cullen PJ. Identification of the Ras GTPase-activating protein GAP1(M) as a phosphatidylinositol-3,4,5-trisphosphate protein in vivo. Curr Biol. 1999;9:265-8.
81. Lowy DR, Willumsen BM. Function and regulation of ras. Annu Rev Biochem. 1993;62:851-91.
82. Luo ZJ, Diaz B, Marshall MS, Avruch J. An intact Raf zinc finger is required for optimal binding to processed Ras and for Ras-dependent Raf activation in situ. Mol Cell Biol. 1997;17:46-53.
83. Marais R, Wynne J, Treisman R. The SRF accessory protein Elk-1 contains a growth factor regulated transcriptional activation domain. Cell. 1993;73:381-93.
84. Marais R, Light Y, Paterson HF, Mason CS, Marshall CJ. Differential regulation of Raf-1, A-Raf, and B-Raf by oncogenic ras and tyrosine kinases. J Biol Chem. 1997;272: 4378-83.
85. Marais R, Light Y, Mason C, Paterson H., Olson MF and Marshall CJ. Requirement of Ras-GTP-Raf complexes for activation of Raf-1 by protein kinase C. Science. 1998;280: 109-12.
86. Marom M, Haklai R, Ben Baruch G, Marciano D, Ezogi Y, Kloog Y. Selective inhibition of Ras-dependent cell growth by farnesylthiosalicylic acid. J Biol Chem. 1995;270:22263-70.
87. Martegani E, Vanoni M, Zippel R, et al. Cloning by functional complementation of a mouse cDNA encoding a homologue of CDC25, a Saccharomyces cerevisiae RAS activator. EMBO J. 1992;11:2151-7.
88. + channel currents. Science. 1992;255:192-94.
89. McGlade J, Brunkhorst B, Anderson D, et al. The N-terminal region of GAP regulates cytoskeletal structure and cell adhesion. EMBO J. 1993;12:3073-81.
90. Medema R, de Laat W, Martin G, McCormick F, Bos JL. GTPase-activating protein SH2-SH3 domains induce gene expression in a Ras-dependent fashion. Mol Cell Biol. 1992;12:3425-30.
91. Melkonian KA, Ostermeyer AG, Chen JZ, Roth MG, Brown DA. Role of lipid modifications in targeting proteins to detergent-resistant membrane rafts - many raft proteins are acylated, while few are prenylated. J Biol Chem. 1999;274: 3910-17.
92. Missy K, VanPoucke V, Raynal P, et al. Lipid products of phosphoinositide 3-kinase interact with rad GTPase and stimulate GDP dissociation. J Biol Chem. 1998;273:30279-86.
93. Moores SL, Schaber MD, Mosser SD, et al. Sequence dependence of protein isoprenylation. J. Biol. Chem. 1991;266: 14603-10.
94. Morrison DK, Cutler RE. The complexity of Raf-1 regulation. Curr Opin Cell Biol. 1997;9:174-9.
95. Nassar N, Horn G, Herrmann C, Scherer A, McCormick F, Wittinghofer A. The 2.2Å crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with Rapl A and a GTP analogue. Nature. 1995; 375:554-60.
96. Nassar N, Horn G, Herrmann C, Block C, Janknecht R, Wittinghofer A. Ras/Rap effector specificity determined by charge reversal. Nature Struct Biol. 1996;3:723-9.
97. Ohnishi M, Yamawaki-Kataoka Y, Kariya K, Tamada M, Hu CD, Kataoka T. Selective inhibition of ras interaction with its particular effector by synthetic peptides corresponding to the ras effector region. J Biol Chem. 1998;273:10210-15.
98. Otto JC, Kim E, Young SG, Casey PJ. Cloning and characterization of a mammalian prenyl protein-specific protease. J Biol Chem. 1999;274:8379-82.
99. Pai EF, Kabsch W, Krengel U, Holmes KC, John J, Wittinghofer A. Structure of the guanine-nucleotide binding domain of the Ha-ras oncogene product p21 in the triphosphate conformation. Nature. 1989;341:209-14.
100. Pai EF, Krengel U, Petsko GA, Goody RS, Kabsch W, Wittinghofer A. Redefined structure of the triphosphate conformation of H-ras p21 at 1.35 A resolution: implications for the mechanism of GTP hydrolysis. EMBO J. 1990; 9:2351-9.
101. Palmero I, Pantoja C, Serrano M. p19(ARF) links the tumour suppressor p53 to Ras. Nature. 1998;395:125-6.
102. Peeper DS, Upton TM, Ladha MH, et al. Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature. 1997;386:177-81.
103. Peli J, Schroter M, Rudaz C, et al. Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas. EMBO J. 1999;18:1824-31.
104. Quaroni A, Paul ECA. Cytocentrin is a Ra1-binding protein involved in the assembly and function of the mitotic apparatus. J Cell Sci. 1999;112:707-18.
105. ras farnesyl:protein transferase by Cys-AAX tetrapeptides. Cell. 1990;62:81-8.
106. H-ras farnesyltransferase. Peptide binding and farnesyl pyrophosphate carrier functions. J Biol Chem. 1991a;266:10672-7.
107. ras protein farnesyltransferase. Proc Natl Acad Sci USA. 1991b;88:732-6.
108. Rodriguez-Viviana P, Warne P, Dhand R, et al. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature. 1994;370:527-32.
109. Rodriguez-Viviana P, Warne P, Vanhaesebroeck B, Waterfield MD, Downward J. Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation. EMBO J. 1996;15:2442-51.
110. Rodriguez-Viviana P, Warne PH, Khwaja A, et al. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell. 1997;89:457-67.
111. Romano JD, Schmidt WK, Michaelis S. The Saccharomyces cerevisiae prenylcysteine carboxyl methyltransferase Ste14p is in the endoplasmic reticulum. Mol Biol Cell. 1998;9: 2231-47.
112. Roy S, Lane A, Yan J, McPherson R, Hancock JF. Activity of plasma membrane-recruited Raf-1 is regulated by Ras via the Raf zinc finger. J Biol Chem. 1997;272:20139-45.
113. Saison-Behmoaras T, Tocqué B, Rey I, Chassignol M, Thuong NT, Hélène C. Short modified antisense oligonucleotides directed against Ha-ras point mutation induce selective cleavage of the mRNA and inhibit T24 cell proliferation. EMBO J. 1991;10:1111-18.
114. Scheffzek K, Ahmadian MR, Kabsch W, et al. The Ras-RasGAP complex: Structural basis for GTPase activation and its loss in oncogenic Ras mutants. Science. 1997;277: 333-8.
115. Schlichting I, Almo SC, Rapp G, et al. Time-resolved X-ray crystallographic study of the conformational change in Ha-ras p21 protein on GTP hydrolysis. Nature. 1990;345:309-15.
116. Schmidt M, Voss M, Thiel M, et al. Specific inhibition of phorbol ester-stimulated phospholipase D by Clostridium sordelii lethal toxiin and Clostridium difficile toxin B-1470 in HEK-293 cells. Restoration by Ra1 GTPases. J Biol Chem. 1998;273:7413-22.
117. Seabra MC. Membrane association and targeting of prenylated Ras-like GTPases. Cell Signal. 1998;10:167-72.
118. Seabra MC, Reiss Y, Casey PJ, Brown MS, Goldstein JL. Protein farnesyltransferase and geranylgeranyltransferase share a common a subunit. Cell. 1991;65:429-34.
119. Sebti S, Hamilton AD. Inhibitors of prenyl transferases. Curr Opin Oncol. 1997;9:557-61.
120. INK4A. Science. 1995;267:249-52.
121. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16(INK4a). Cell. 1997;88:593-602.
122. Shou C, Farnsworth CL, Neel BG, Feig L. A. Molecular cloning of cDNAs encoding a guanine-nucleotide-releasing factor for ras p21. Nature. 1992;358:351-4.
123. Siddiqui AA, Garland JR, Dalton MB, Sinensky M. Evidence for a high affinity, saturable, prenylation-dependent p21(Ha-ras) binding site in plasma membranes. J Biol Chem. 1998;273:3712-17.
124. Sieburth DS, Sun Q, Han M. SUR-8, a conserved Ras-binding protein with leucine-rich repeats, positively regulates Ras-mediated signaling in C. elegans. Cell. 1998;94:119-30.
125. Stokoe D, McCormick F. Activation of c-Raf-1 by Ras and Src through different mechanisms: activation in vivo and in vitro. EMBO J. 1997;16:2384-96.
126. Stokoe D, MacDonald SG, Cadwallader K, Symons M, Hancock J. Activation of Raf as a result of recruitment to the palsma membrane. Science. 1994;264:1463-76.
127. Storm SM, Cleveland JL, Rapp UR. Expression of raf family proto-oncogenes in normal mouse tissues. Oncogene. 1990; 5:345-51.
128. Tabin C, Bradley SM, Bargmann CI, et al. Mechanism of activation of a human oncogene. Nature. 1982;300:143-9.
129. Taparowsky E, Suard Y, Fasano O, Shimizu K, Goldfarb M, Wigler M. Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change. Nature. 1982;300:762-5.
130. Taylor SJ, Shalloway D. Cell cycle-dependent activation of Ras. Curr Biol. 1996;6:1621-7.
131. --activated Giα1: stabilization of the transition state for GTP hydrolysis. Cell. 1997;89:251-61.
132. Tocque B, Delumeau I, Parker F, Maurier F, Multon MC, Schweighoffer F. Ras-GTPase activating protein (GAP): a putative effector for Ras. Cell Signal. 1997;9:153-8.
133. Trahey M, McCormick F. A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants. Science. 1987;238:542-5.
134. Urano T, Emkey R, Feig LA. Ra1-GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation. EMBO J. 1996;15:810-16.
135. Van Aelst L, Barr M, Marcus S, Polverino A, Wigler M. Complex formation between Ras and Raf and other protein kinases. Proc Natl Acad Sci USA. 1993;90:6213-17.
136. vanWeeren PC, deBruyn KMT, deVriesSmits AMM, vanLint J, Burgering BMT. Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation - characterization of dominant-negative mutant of PKB. J Biol Chem. 1998;273:13150-6.
137. vanWeering DHJ, deRooij J, Marte B, Downward J, Bos JL, Burgering BMT. Protein kinase B activation and lamellipodium formation are independent phosphoinositide 3-kinase-mediated events differentially regulated by endogenous Ras. Mol Cell Biol. 1998;18:1802-11.
138. Vavvas D, Li X, Avruch J, Zhang XF. Identification of Nore1 as a potential Ras effector. J Biol Chem. 1998;273:5439-42.
139. Vogel US, Dixon RA, Schaber MD, et al. Cloning of bovine GAP and its interaction with oncogenic ras p21. Nature. 1988;355:90-3.
140. Vojtek AB, Der CJ. Increasing complexity of the Ras signaling pathway. J Biol Chem. 1998;273:19925-8.
141. Vojtek AB, Hollenberg SM, Cooper JA. Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell. 1993;74:205-14.
142. Wallace A, Koblan KS, Hamilton K, et al. Selection of potent inhibitors of farnesyl-protein transferase from a synthetic tetrapeptide combinatorial library. J Biol Chem. 1996;271: 31306-11.
143. Warne PH, Rodriguez-Viviana P, Downward J. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro. Nature. 1993;364:352-5.
144. White MA, Nicolette C, Minden A, et al. Multiple Ras functions can contribute to mammalian cell transformation. Cell. 1995;80:533-41.
145. White MA, Vale T, Camonis JH, Schaefer E, Wigler MH. A role for the Ra1 guanine nucleotide dissociation stimulator in mediating Ras-induced transformation. J Biol Chem. 1996; 271:16439-42.
146. Whitmarsh AJ, Cavanagh J, Tournier C, Yasuda J, Davis RJ. A mammalian scaffold complex that selectively mediates MAP kinase activation. Science. 1998;281:1671-4.
147. Willumsen BM, Norris K, Papageorge AG, Hubbert NL, Lowy DR. Harvey murine sarcoma virus p21 ras protein: biological and biochemical significance of the cysteine nearest the carboxy terminus. EMBO J. 1984;3:2581-5.
148. Wittinghofer A, Nassar N How Ras-related proteins talk to their effectors. Trends Biochem Sci. 1996;21:488-91.
149. Wolthuis RMF, Bauer B, van't Veer LJ, et al. Ra1GDS-like factor (R1f) is a novel Ras and Rap 1A-associating protein. Oncogene. 1996;13:353-62.
150. Wolthuis RMF, deRuiter ND, Cool RH, Bos JL. Stimulation of gene induction and cell growth by the Ras effector R1f. EMBO J. 1997;16:6748-61.
151. Wolthuis RMF, Zwartkruis F, Moen TC, Bos JL. Ras-dependent activation of the small GTPase Ra1. Curr Biol. 1998;8:471-4.
152. Yamaguchi A, Urano T, Goi T, Feig LA. An eps homology (EH) domain protein that binds to the Ra1-GTPase target, Ra1BP1. J Biol Chem. 1997;272:3123-4.
153. Yamamoto T, Harada N, Kano K, et al. The Ras target AF-6 interacts with ZO-1 and serves as a peripheral component of tight junctions in epithelial cells. J Cell Biol. 1997;139:785-95.
154. Zhang K, Papageorge AG, Martin P, et al. Heterogenous amino acids in ras and raplA specifying sensitivity to GAP proteins. Science. 1991;254:1630-3.
155. ras proteins bind to the amino-terminal regulatory domain of c-Raf-1. Nature. 1993;364:308-13.